G
Gordon H. Guyatt
Researcher at McMaster University
Publications - 1749
Citations - 262329
Gordon H. Guyatt is an academic researcher from McMaster University. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 231, co-authored 1620 publications receiving 228631 citations. Previous affiliations of Gordon H. Guyatt include Memorial Sloan Kettering Cancer Center & Cayetano Heredia University.
Papers
More filters
Journal ArticleDOI
Antithrombotic and thrombolytic therapy: from evidence to application: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Holger J. Schünemann,Deborah J. Cook,Jeremy M. Grimshaw,Alessandro Liberati,John E. Heffner,Victor F. Tapson,Gordon H. Guyatt +6 more
TL;DR: There are few implementation strategies that are of unequivocal, consistent benefit, and that are clearly and consistently worth resource investment, and fully informed decisions will require additional research to identify effective guideline implementation strategies.
Journal ArticleDOI
Analysis of the burden of treatment in patients receiving an EpiPen for yellow jacket anaphylaxis.
TL;DR: In contrast to VIT, the EpiPen is perceived as burdensome by most patients with venom allergy, and patients should be offered VIT.
Journal ArticleDOI
Effect of Air Filtration Systems on Asthma : A Systematic Review of Randomized Trials
TL;DR: Among patients with allergies and asthma, use of air filters is associated with fewer symptoms and Rigorous sufficiently powered randomized clinical trials are needed to more precisely define the influence of air filtration on health-related quality of life and symptom control for asthmatic patients.
Journal ArticleDOI
Digitalis for treatment of congestive heart failure in patients in sinus rhythm: a systematic review and meta-analysis
TL;DR: The literature indicates that the drug has no effect on long-term mortality, but reduces the incidence of hospitalization, and has a positive effect on the clinical status of symptomatic patients.
Journal ArticleDOI
Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysis
TL;DR: In this paper, the authors performed a meta-analysis using random effects models to estimate overall survival, event-free survival, and risks of adverse outcomes, and found that high-dose therapy and ASCT as part of initial treatment does not improve overall survival.